Feed HNORY
HN

Harvey Norman Holdings Limited

HNORY · OTC

$14.73 +0.00% (+$0.00)
Market Cap $5.23B
P/E Ratio 10.13x
Div. Yield 6.75%
ROE 10.73%

Bulios Fair Price

$18.17

23.4% upside

Current Price

$14.73

Undervalued Fair Value Overvalued

According to Bulios Fair Price, HNORY is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Strong
7/9
Valuation
95 /100
Cheap
P/B 1.07x
P/S 1.24x
P/E 10.13x
Growth
21 /100
Declining
Book val. growth 3.39%
FCF growth 8.43%
EPS growth 0.78%
Profitability
74 /100
Strong
FCF margin 8.97%
Op. margin 18.12%
Gross margin 46.80%
Quality
42 /100
Average
Asset turnover 0.48x
ROA 5.84%
ROIC 6.33%
Debt
67 /100
Low
Net debt/EBITDA 2.43x
Int. coverage 6.17x
Debt/Equity 0.53x
Stability
84 /100
Stable
Profitable years 6
EPS volatility 42.67%
Beta 0.73x

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about HNORY
Online

Sector

Consumer Cyclical

Industry

Specialty Retail

CEO

Kay Lesley Harvey Page

Employees

6,500

Headquarters

Homebush West

Upcoming events

07 OCT

Ex-Dividend

Ex-dividend date

9d
02 DEC

Dividend Payment

Payment date

65d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.